Cargando…
Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR(−/−) mice
Fenretinide is a synthetic retinoid that can prevent obesity and improve insulin sensitivity in mice by directly altering retinol/retinoic acid homeostasis and inhibiting excess ceramide biosynthesis. We determined the effects of Fenretinide on LDLR(−/−) mice fed high-fat/high-cholesterol diet ± Fen...
Autores principales: | Thompson, Dawn, Mahmood, Shehroz, Morrice, Nicola, Kamli-Salino, Sarah, Dekeryte, Ruta, Hoffmann, Philip A., Doherty, Mary K., Whitfield, Philip D., Delibegović, Mirela, Mody, Nimesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998859/ https://www.ncbi.nlm.nih.gov/pubmed/36894641 http://dx.doi.org/10.1038/s41598-023-30759-w |
Ejemplares similares
-
Myeloid PTP1B deficiency protects against atherosclerosis by improving cholesterol homeostasis through an AMPK-dependent mechanism
por: Oliver, Helk, et al.
Publicado: (2023) -
Elevated Fibroblast growth factor 21 (FGF21) in obese, insulin resistant states is normalised by the synthetic retinoid Fenretinide in mice
por: Morrice, Nicola, et al.
Publicado: (2017) -
Fenretinide mediated retinoic acid receptor signalling and inhibition of ceramide biosynthesis regulates adipogenesis, lipid accumulation, mitochondrial function and nutrient stress signalling in adipocytes and adipose tissue
por: Mcilroy, George D., et al.
Publicado: (2016) -
Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR(−/−) mouse model of atherosclerosis
por: Thompson, Dawn, et al.
Publicado: (2017) -
Neuronal human BACE1 knockin induces systemic diabetes in mice
por: Plucińska, Kaja, et al.
Publicado: (2016)